# Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts

**Authors:** Albert Kallon Koroma, Karmveer Singh, Yongfang Wang, Linda Krug, Philipp Haas, Meinhard Wlaschek, Vadim Sakk, Tanja Schuster, Daniel Fürst, Hubert Schrezenmeier, Rashmi Priyadharshini Dheenadayalan, Stephan Stilgenbauer, Lutz Walter, Hartmut Geiger, Karin Scharffetter‐Kochanek, Pallab Maity

PMC · DOI: 10.1111/acel.70398 · Aging Cell · 2026-02-08

## TL;DR

Old NK cells fail to kill senescent fibroblasts due to overactive Cdc42, which can be partially reversed with a drug called CASIN.

## Contribution

Identifies overactivation of Cdc42 GTPase as a novel mechanism for impaired NK cell function in aging.

## Key findings

- Aged NK cells show reduced perforin and granzyme B release due to disrupted microtubular organization.
- Cdc42 overactivation in aged NK cells is linked to impaired mitochondrial ATP production.
- CASIN treatment restores NK cell cytotoxicity by rebalancing Cdc42 activity.

## Abstract

Senescent fibroblasts accumulate in the connective tissue of all organs and promote organ aging and aging‐related diseases. The underlying mechanisms for the accumulation of senescent fibroblasts are poorly understood. Natural killer (NK) cells of innate immunity play a critical role in the removal of tissue resident senescent cells. We here show that NK cells from old adults and old mice fail to efficiently remove senescent fibroblasts. This is due to severely reduced perforin and granzyme B release from aged NK cells where perforin is responsible for inducing holes in the membrane of senescent fibroblasts through which granzyme B enters enforcing cell death of senescent fibroblasts. We demonstrate elevated activation of the small Cdc42 Rho GTPase in aged NK cells to be responsible for the disruption of the microtubular organization which is essential for the proper release of perforin and granzyme B and for energy homeostasis. Attenuation of the elevated activity of Cdc42 in aged human NK cells with CASIN, a small molecule Cdc42 inhibitor, rebalances Cdc42 activity to a young level. Rebalancing of Cdc42 restores proper perforin and granzyme B release and attenuates reduced ATP levels in aged NK cells resulting in an attenuated “youthful” cytotoxicity of aged NK cells against senescent cells. Collectively, we identified a previously unreported molecular mechanism underlying functional impairment of NK cells from older adults. In perspective, our data hold promise to develop novel strategies against age‐related disorders driven by tissue‐resident senescent fibroblasts.

Unrestrained Cdc42 activity causes failure of cytotoxic function of old NK cells. This is associated with disruption of microtubular network and impaired mitochondrial ATP resulting in reduced conjugation and impaired degranulation of lytic vesicles. Pharmacological inhibition of Cdc42 by CASIN attenuates all these and in part rejuvenates the cytotoxicity.

## Linked entities

- **Genes:** CDC42 (cell division cycle 42) [NCBI Gene 998]
- **Proteins:** PRF1 (perforin 1), CDC42 (cell division cycle 42)
- **Chemicals:** CASIN (PubChem CID 2882155)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** MICB (MHC class I polypeptide-related sequence B) [NCBI Gene 4277] {aka PERB11.2}, ATP11A (ATPase phospholipid transporting 11A) [NCBI Gene 23250] {aka ATPIH, ATPIS, AUNA2, DFNA84, HLD24}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, MICA (MHC class I polypeptide-related sequence A) [NCBI Gene 100507436] {aka MIC-A, PERB11.1}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, Fcr (Fc receptor) [NCBI Gene 109615], GZMB (granzyme B) [NCBI Gene 490630], Lamp1 (lysosomal-associated membrane protein 1) [NCBI Gene 16783] {aka CD107a, LGP-120, LGP-A, Lamp-1, P2B, Perk}, NGFR (nerve growth factor receptor) [NCBI Gene 4804] {aka CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR}, CAT (catalase) [NCBI Gene 847], KMT2A (lysine methyltransferase 2A) [NCBI Gene 4297] {aka ALL-1, ALL1, CXXC7, GAS7, HRX, HTRX}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, ANK3 (ankyrin 3) [NCBI Gene 288] {aka ANKYRIN-G, MRT37}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, SH3RF1 (SH3 domain containing ring finger 1) [NCBI Gene 57630] {aka POSH, RNF142, SH3MD2}, LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, Ncam1 (neural cell adhesion molecule 1) [NCBI Gene 17967] {aka CD56, E-NCAM, NCAM-1, Ncam}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, HLA-E (major histocompatibility complex, class I, E) [NCBI Gene 3133] {aka HLA-6.2, QA1}, TEC (tec protein tyrosine kinase) [NCBI Gene 7006] {aka PSCTK4}, MS4A3 (membrane spanning 4-domains A3) [NCBI Gene 932] {aka CD20L, HTM4}, NDC80 (NDC80 kinetochore complex component) [NCBI Gene 10403] {aka HEC, HEC1, HsHec1, KNTC2, TID3, hsNDC80}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, Klrb1c (killer cell lectin-like receptor subfamily B member 1C) [NCBI Gene 17059] {aka CD161, Klrb1b, Ly-59, Ly55c, Ly59, NK-RP1}, KLRC1 (killer cell lectin like receptor C1) [NCBI Gene 3821] {aka CD159A, NKG2, NKG2A}, SNAP25 (synaptosome associated protein 25) [NCBI Gene 6616] {aka CMS18, DEE117, RIC-4, RIC4, SEC9, SNAP}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Cdc42 (cell division cycle 42) [NCBI Gene 12540], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}
- **Diseases:** Trauma (MESH:D014947), Chronic Myelogenous Leukemia (MESH:D015464), Mantle cell lymphoma (MESH:D020522), diabetes (MESH:D003920), HDF (MESH:D016136), hematological malignancies (MESH:D019337), inflammatory (MESH:D007249), CLL (MESH:D015451), Allergic Diseases (MESH:D004342), arteriosclerosis (MESH:D001161), neurodegenerative disorders (MESH:D019636), spike (MESH:D031261), mitochondrial dysfunction (MESH:D028361), infections (MESH:D007239), osteoarthritis (MESH:D010003), lymphoma (MESH:D008223), Cytotoxicity (MESH:D064420), age- (MESH:D019588), NK (MESH:D000077428), Cancer (MESH:D009369), leukemia (MESH:D007938)
- **Chemicals:** antimycin (MESH:C032456), oxygen (MESH:D010100), alpha-MEM (MESH:C420642), rotenone (MESH:D012402), oligomycin (MESH:D009840), ATP (MESH:D000255), penicillin (MESH:D010406), GDP (MESH:D006153), FCCP (MESH:D002259), NP-40 (MESH:C010615), Triton X-100 (MESH:D017830), DMSO (MESH:D004121), streptomycin (MESH:D013307), sulfuric acid (MESH:C033158), H+ (MESH:D006859), alcohol (MESH:D000438), cyclodextrin (MESH:D003505), Pen (MESH:C058388), NaCl (MESH:D012965), water (MESH:D014867), Paraffin (MESH:D010232), CO2 (MESH:D002245), PBS (MESH:D007854), J (MESH:C000608249), pyruvate (MESH:D019289), glucose (MESH:D005947), JC-1 (MESH:C068624), DAPI (MESH:C007293), sodium deoxycholate (MESH:D003840), CASIN (MESH:C000719991), L-glutamate (MESH:D018698), TCA (MESH:D014238), histamine (MESH:D006632), GTP (MESH:D006160), SDS (MESH:D012967), sodium citrate (MESH:D000077559), xylene (MESH:D014992), CFSE (MESH:C087165), doxorubicin (MESH:D004317), Peroxide (MESH:D010545), purine (MESH:C030985), L-Glutamine (MESH:D005973), AF5779 (-), Calcein (MESH:C007740)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 10HU- — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_7207), JVM-2 — Homo sapiens (Human), Mantle cell lymphoma, Transformed cell line (CVCL_1319), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), CCL- — Mus musculus (Mouse), Undefined cell line type (CVCL_M023), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), HG-3 — Homo sapiens (Human), Chronic lymphocytic leukemia, Transformed cell line (CVCL_Y547), YAC-1 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_2244), OSU-CLL — Canis lupus familiaris (Dog), Canine leukemia, Cancer cell line (CVCL_DI62), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), D1515- — Homo sapiens (Human), Transformed cell line (CVCL_9G22), C34570 — Mus musculus (Mouse), Finite cell line (CVCL_S361), HDF — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U509), ATCC — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883145/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12883145/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883145/full.md

---
Source: https://tomesphere.com/paper/PMC12883145